ask="40.35"
ask_size="100"
average_daily_volume="284926"
bid="32.40"
bid_size="200"
book_value="6.19"
change="+1.38"
change_from_200_day_moving_average="3.01"
change_from_50_day_moving_average="2.30"
change_from_52_week_high="-5.14"
change_From_52_week_low="20.19"
change_in_percent="+4.26%"
close="33.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31720000"
high="33.91"
high_52_weeks="38.92"
last_trade_date="2/17/2017"
last_trade_price="33.78"
last_trade_size="38805"
last_trade_time="4:00pm"
low="32.35"
low_52_weeks="13.59"
market_capitalization="1.75B"
moving_average_200_day="30.77"
moving_average_50_day="31.48"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="32.40"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+9.78%"
percent_change_from_50_day_moving_average="+7.31%"
percent_change_from_52_week_high="-13.21%"
percent_change_from_52_week_low="+148.57%"
previous_close="32.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.23"
price_per_sales="35.92"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="272735"
weeks_range_52="13.59 - 38.92"
